Join DIA's Advanced Therapies Community for this upcoming webinar.

The US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) will facilitate a discussion on the topic of FDA programs and relevant policies available to support and advance the development and evaluation of new treatments for rare diseases.